All news from Anaesthesiology

Universal Influenza Vaccine: Strategic Plan for its Development

Developing a universal influenza vaccine — a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic — is a priority for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

For-Profit System Drives High US Health Costs

A new study published in JAMA shows that high healthcare spending in the U.S. stems not just from elevated prescription drug costs or its fee-for-service model—but from high costs across the American healthcare industry. The United States spends nearly double what 10 other wealthy nations spend on healthcare, researchers report.

New Protein Structure Related To Neurodegenerative Disorders

In this study, researchers have determined the structure of a key protein that is involved in the body's inflammatory response. This finding opens the door to developing new treatments for a wide range of illnesses, from heart disease, diabetes, and cancer to neurodegenerative disorders, including Parkinson's disease. The studies on protein structures at the atomic resolution level to understand the mechanism of their function in the body.

Role for Predictive Biomarker in Neonatal Chronic Lung Disease Pathogenesis

Extremely low birth-weight babies are at risk for a chronic lung disease called bronchopulmonary dysplasia, or BPD. This condition can lead to death or long-term disease, but clinical measurements are unable to predict which of the tiny infants -; who get care in hospital intensive-care units and often weigh just one and a half pounds -; will develop BPD.

Researchers Find Key Step in Viral Replication

A new study, published in the journal Nature Microbiology, provide insight into how a common virus hijacks a host cell's protein to help assemble new viruses before they are released. The results increase our understanding of how viruses reproduce in the body and establish a rationale for the development of protein inhibitor as potential antiviral therapeutics.